HLA involvement in nevirapine-induced dermatological reaction in antiretroviral-treated HIV-1 patients

Journal of Pharmacology and Pharmacotherapeutics

Volumn 2, Issue 2, 2011, Pages 114-115

  Umapathy, Shankarkumar ^a   Pawar, A ^a   Bajpai, S ^a   Pazare, A R ^a   Ghosh, K ^a  

^a KEM HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA B15 ANTIGEN; HLA B35 ANTIGEN; HLA B7 ANTIGEN; HLA B8 ANTIGEN; NEVIRAPINE;

ADVERSE OUTCOME; ANTIGEN DETECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; GENE FREQUENCY; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREACTIVITY; INDIA; LETTER; MALE; SKIN MANIFESTATION; SKIN PRURITUS; STEVENS JOHNSON SYNDROME; TREATMENT DURATION;

EID: 84865517113     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.81905     Document Type: Letter

References (6)

1. Harminder S, Dulhani N, Tiwari P, Singh P, Sinha T. A prospective observational cohort study to elicit adverse effects of antiretroviral agents in a remote resourse-restricted tribal population of Chhattisgarh. Indian J Pharmacol 2009;41:224-8.
2. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000;356:1423-30.
3. Dieterich D T, Robinson PA, Love J, Stern JO. Drug-induced liver injury with the use of nonnucleoside reverse transcriptase inhibitors Clin Infect Dis 2004;38:S80-9.
4. *04 allele associated with nevirapine-induced rash in HIV-infected Thai Patients. AIDS Res Ther 2009;6:22.
5. Littera R, Carcassi C, Masala A, Plano P, Serra P, Ortu F, et al. HLA dependant hypersensitivity to nevirapine in Sardinian HIV patients. AIDS 2006;20:1621-6.
6. *3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV infected Thai patients. Pharmacogenet Genomics 2009;19:139-46.